Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Immune response to Bordetella pertussis is associated with season and undernutrition in Senegalese children.

Gaayeb L, Pinçon C, Cames C, Sarr JB, Seck M, Schacht AM, Remoué F, Hermann E, Riveau G.

Vaccine. 2014 Jun 5;32(27):3431-7. doi: 10.1016/j.vaccine.2014.03.086. Epub 2014 Apr 14.

PMID:
24726248
2.

Seroprevalence of pertussis in Senegal: a prospective study.

Gaayeb L, Sarr JB, Ndiath MO, Hanon JB, Debrie AS, Seck M, Schacht AM, Remoué F, Hermann E, Riveau G.

PLoS One. 2012;7(10):e48684. doi: 10.1371/journal.pone.0048684. Epub 2012 Oct 31.

4.

Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.

Salmaso S, Mastrantonio P, Tozzi AE, Stefanelli P, Anemona A, Ciofi degli Atti ML, Giammanco A; Stage III Working Group.

Pediatrics. 2001 Nov;108(5):E81.

PMID:
11694665
5.

Evidence of Bordetella pertussis infection in vaccinated 1-year-old Danish children.

von Linstow ML, Pontoppidan PL, von König CH, Cherry JD, Hogh B.

Eur J Pediatr. 2010 Sep;169(9):1119-22. doi: 10.1007/s00431-010-1192-9. Epub 2010 Apr 8.

6.

Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine.

Dalby T, Petersen JW, Harboe ZB, Krogfelt KA.

J Med Microbiol. 2010 Sep;59(Pt 9):1029-36. doi: 10.1099/jmm.0.020826-0. Epub 2010 May 27.

PMID:
20508003
7.

A novel method for evaluating natural and vaccine induced serological responses to Bordetella pertussis antigens.

Berbers GA, van de Wetering MS, van Gageldonk PG, Schellekens JF, Versteegh FG, Teunis PF.

Vaccine. 2013 Aug 12;31(36):3732-8. doi: 10.1016/j.vaccine.2013.05.073. Epub 2013 Jun 3.

PMID:
23742995
8.

Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection.

Hallander HO, Ljungman M, Jahnmatz M, Storsaeter J, Nilsson L, Gustafsson L.

APMIS. 2009 Sep;117(9):660-71. doi: 10.1111/j.1600-0463.2009.02521.x.

PMID:
19703126
9.

Different IgG-subclass distributions after whole-cell and acellular pertussis infant primary vaccinations in healthy and pertussis infected children.

Hendrikx LH, Schure RM, Oztürk K, de Rond LG, de Greeff SC, Sanders EA, Berbers GA, Buisman AM.

Vaccine. 2011 Sep 16;29(40):6874-80. doi: 10.1016/j.vaccine.2011.07.055. Epub 2011 Jul 29.

PMID:
21803088
10.

[Seroepidemiology of pertussis in 10-15 years old healthy children in Isparta province, Turkey].

Seçkin H, Ormeci AR, Sandal G, Kaya S.

Mikrobiyol Bul. 2013 Jul;47(3):507-13. Turkish.

11.

Analogous IgG subclass response to pertussis toxin in vaccinated children, healthy or affected by whooping cough.

Giammanco A, Taormina S, Chiarini A, Dardanoni G, Stefanelli P, Salmaso S, Mastrantonio P.

Vaccine. 2003 May 16;21(17-18):1924-31.

PMID:
12706678
12.

[Contents of antibodies to Bordetella pertussis antigens in patients with rheumatic diseases].

Kostinov MP, Tarasova AA, Zaĭtsev EM.

Zh Mikrobiol Epidemiol Immunobiol. 2007 Nov-Dec;(6):61-4. Russian.

PMID:
18277540
13.

Antibody response from whole-cell pertussis vaccine immunized Brazilian children against different strains of Bordetella pertussis.

Pereira A, Pietro Pereira AS, Silva CL, de Melo Rocha G, Lebrun I, Sant'Anna OA, Tambourgi DV.

Am J Trop Med Hyg. 2010 Apr;82(4):678-82. doi: 10.4269/ajtmh.2010.09-0486.

14.

[Humoral imunity to pertussis in children with diabetes of type 1].

Tarasova AA, Kostinov MP, Zaĭtsev EM.

Zh Mikrobiol Epidemiol Immunobiol. 2006 May-Jun;(3):53-7. Russian.

PMID:
16830591
15.

Risk factors for acellular and whole-cell pertussis vaccine failure in Senegalese children.

Lacombe K, Yam A, Simondon K, Pinchinat S, Simondon F.

Vaccine. 2004 Dec 16;23(5):623-8.

PMID:
15542182
16.

[Detection of Bordetella pertussis infection by culture, real-time polymerase chain reaction and serologic tests among children with prolonged cough].

Gürsel D, Aslan A, Sönmez C, Koturoğlu G, Cöplü N, Kurugöl Z, Aydemir S.

Mikrobiyol Bul. 2012 Apr;46(2):211-24. Turkish.

PMID:
22639310
17.

Seroprevalence of IgG antibodies to pertussis toxin in the Slovene population.

Socan M, Prosenc K, Vegnuti M.

Wien Klin Wochenschr. 2006 Jun;118(11-12):336-40.

PMID:
16855922
18.
19.

The seroepidemiology of Bordetella pertussis in Israel--Estimate of incidence of infection.

Rendi-Wagner P, Tobias J, Moerman L, Goren S, Bassal R, Green M, Cohen D.

Vaccine. 2010 Apr 26;28(19):3285-90. doi: 10.1016/j.vaccine.2010.02.104. Epub 2010 Mar 10.

PMID:
20226250
20.

Parapertussis and pertussis: differences and similarities in incidence, clinical course, and antibody responses.

Bergfors E, Trollfors B, Taranger J, Lagergård T, Sundh V, Zackrisson G.

Int J Infect Dis. 1999 Spring;3(3):140-6.

Supplemental Content

Support Center